International Biotechnology Trust plc EBIT

International Biotechnology Trust plc posts a EBIT of $96M as of February 2026. That compares with $56M in the prior-year period — up 73.4% year over year. That is above the sector sector average of $-25M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, International Biotechnology Trust plc's EBIT was $56M. The latest reading is $96M — a 73.4% year-over-year increase (period ending February 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a EBIT near $-25M is typical. International Biotechnology Trust plc's $96M is higher that level. That is roughly 480.5% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of International Biotechnology Trust plc's financial statement story. At $96M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IBT.L's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $-25M), and (3) consistency with growth and profitability. This page covers the first two; International Biotechnology Trust plc's other metric pages and overview cover the third.